What is TC:HDL-C ratio (Total Cholesterol to HDL Cholesterol Ratio)?

The TC:HDL-C ratio divides your total cholesterol by HDL cholesterol to assess cardiovascular risk, with lower ratios indicating better heart health. A ratio below 3.5 is optimal, while ratios above 5.0 suggest increased risk for heart disease and stroke.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

When it comes to understanding your heart health, cholesterol numbers can feel like a complex puzzle. While you might be familiar with total cholesterol or "good" HDL cholesterol, there's a powerful metric that combines these values to give you a clearer picture of your cardiovascular risk: the TC:HDL-C ratio, or total cholesterol to HDL cholesterol ratio.

This simple calculation has emerged as one of the most reliable predictors of heart disease risk, often providing more insight than looking at individual cholesterol values alone. By understanding what this ratio means and how to optimize it, you can take meaningful steps toward protecting your cardiovascular health for years to come.

Understanding the TC:HDL-C Ratio

The TC:HDL-C ratio is calculated by dividing your total cholesterol level by your HDL (high-density lipoprotein) cholesterol level. For example, if your total cholesterol is 200 mg/dL and your HDL cholesterol is 50 mg/dL, your ratio would be 4.0 (200 ÷ 50 = 4).

TC:HDL-C Ratio Risk Categories

Risk categories based on American Heart Association guidelines. Individual risk may vary based on other factors.
TC:HDL-C RatioRisk CategoryInterpretationRecommended Action
Below 3.5Below 3.5OptimalExcellent cardiovascular healthMaintain healthy lifestyle
3.5-5.03.5-5.0BorderlineModerate riskConsider lifestyle modifications
5.1-6.05.1-6.0High RiskElevated cardiovascular riskImplement lifestyle changes, consult healthcare provider
Above 6.0Above 6.0Very High RiskSignificantly elevated riskUrgent medical consultation recommended

Risk categories based on American Heart Association guidelines. Individual risk may vary based on other factors.

This ratio matters because it captures the balance between all cholesterol in your blood and the protective HDL cholesterol that helps remove excess cholesterol from your arteries. HDL cholesterol acts like a cleanup crew, transporting cholesterol from your blood vessels back to your liver for disposal. When this ratio is high, it suggests you have too much cholesterol relative to your body's ability to clear it away.

Research has consistently shown that the TC:HDL-C ratio is a stronger predictor of cardiovascular disease than total cholesterol alone. A landmark study in The Lancet found that this ratio was one of the most powerful indicators of heart attack risk across diverse populations worldwide.

Optimal TC:HDL-C Ratio Ranges

Understanding where your ratio falls on the risk spectrum is crucial for assessing your cardiovascular health. Medical professionals use established ranges to evaluate heart disease risk based on this ratio.

These ranges apply to both men and women, though women typically have higher HDL levels and therefore often have more favorable ratios. It's worth noting that the American Heart Association considers ratios above 5.0 to indicate approximately double the average risk for heart disease.

If you're interested in understanding your cholesterol ratios and overall cardiovascular health markers, comprehensive testing can provide valuable insights into your heart disease risk.

Gender Differences in TC:HDL-C Ratios

Women generally have higher HDL cholesterol levels than men, particularly before menopause. This biological advantage often results in more favorable TC:HDL-C ratios for women. However, after menopause, women's HDL levels may decline and their ratios can worsen, emphasizing the importance of regular monitoring throughout life.

Your TC:HDL-C ratio typically changes with age. Total cholesterol tends to increase until about age 65, while HDL levels may remain relatively stable or decline slightly. This can lead to gradually worsening ratios over time, making it important to track this biomarker regularly as you age.

Why the TC:HDL-C Ratio Matters More Than Total Cholesterol

Total cholesterol alone can be misleading. You might have high total cholesterol but also very high HDL cholesterol, which actually indicates good cardiovascular health. Conversely, someone with "normal" total cholesterol but very low HDL could be at significant risk for heart disease.

The ratio provides context by showing the relationship between protective and potentially harmful cholesterol. Studies have demonstrated that people with favorable ratios (below 3.5) have significantly lower rates of coronary artery disease, even if their total cholesterol is elevated.

Additionally, the TC:HDL-C ratio responds well to lifestyle interventions. Unlike some biomarkers that are largely genetic, this ratio can improve dramatically with diet, exercise, and other lifestyle modifications, making it a valuable metric for tracking your progress.

Factors That Affect Your TC:HDL-C Ratio

Dietary Influences

Your diet plays a crucial role in determining your TC:HDL-C ratio. Saturated and trans fats tend to raise total cholesterol more than HDL, worsening your ratio. On the other hand, monounsaturated fats (found in olive oil, avocados, and nuts) and omega-3 fatty acids (from fatty fish) can improve your ratio by raising HDL levels.

  • Foods that improve your ratio: fatty fish, nuts, olive oil, avocados, whole grains, and legumes
  • Foods that worsen your ratio: processed meats, fried foods, baked goods with trans fats, and excessive saturated fats
  • Moderate alcohol consumption (particularly red wine) may increase HDL, but excessive drinking harms cardiovascular health

Physical Activity and Exercise

Regular physical activity is one of the most effective ways to improve your TC:HDL-C ratio. Aerobic exercise, in particular, can increase HDL cholesterol by 5-10% while also helping to lower total cholesterol. The American Heart Association recommends at least 150 minutes of moderate-intensity exercise per week for optimal cardiovascular health.

Other Lifestyle Factors

Several other factors influence your ratio:

  • Smoking significantly lowers HDL cholesterol, worsening your ratio
  • Excess weight, particularly abdominal fat, negatively impacts both total cholesterol and HDL
  • Chronic stress can raise total cholesterol and lower HDL through hormonal pathways
  • Certain medications (like beta-blockers or anabolic steroids) may adversely affect your ratio

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

How to Improve Your TC:HDL-C Ratio

Improving your TC:HDL-C ratio requires a two-pronged approach: lowering total cholesterol while raising HDL cholesterol. Here are evidence-based strategies to achieve both goals:

Dietary Strategies

  1. Replace saturated fats with unsaturated fats: Use olive oil instead of butter, choose lean proteins, and incorporate more plant-based meals
  2. Increase soluble fiber intake: Aim for 25-35 grams daily from oats, beans, apples, and barley to help lower total cholesterol
  3. Add plant sterols and stanols: These compounds, found in fortified foods and supplements, can reduce cholesterol absorption
  4. Embrace the Mediterranean diet pattern: Rich in healthy fats, whole grains, and vegetables, this eating style consistently improves cholesterol ratios

Exercise Recommendations

Different types of exercise offer unique benefits for your cholesterol profile:

  • Aerobic exercise: Running, cycling, or swimming for 30-60 minutes most days can increase HDL by up to 10%
  • High-intensity interval training (HIIT): Short bursts of intense activity may be particularly effective for raising HDL
  • Resistance training: While primarily beneficial for muscle health, strength training can modestly improve cholesterol ratios
  • Consistency matters: Regular moderate exercise often produces better results than sporadic intense workouts

Weight Management

Even modest weight loss can significantly improve your TC:HDL-C ratio. Losing just 5-10% of body weight can increase HDL cholesterol by 5 mg/dL and reduce total cholesterol. Focus on sustainable changes rather than extreme diets, as yo-yo dieting can actually worsen your cholesterol profile.

When to Test Your TC:HDL-C Ratio

The American Heart Association recommends that adults have their cholesterol checked every 4-6 years starting at age 20. However, more frequent testing may be warranted if you have risk factors such as family history of heart disease, diabetes, high blood pressure, or if you're making lifestyle changes to improve your cardiovascular health.

For accurate results, you typically need to fast for 9-12 hours before a cholesterol test. This ensures that recent meals don't affect your readings. Some newer tests don't require fasting, but it's best to follow your healthcare provider's instructions.

Regular monitoring of your TC:HDL-C ratio and other cardiovascular biomarkers can help you track the effectiveness of lifestyle changes and catch potential issues early.

The TC:HDL-C Ratio in Context with Other Biomarkers

While the TC:HDL-C ratio is valuable, it's most informative when considered alongside other cardiovascular biomarkers. Modern cardiovascular risk assessment often includes:

  • ApoB (Apolipoprotein B): Measures the number of atherogenic particles in your blood
  • Triglycerides: High levels can indicate metabolic dysfunction and increased cardiovascular risk
  • LDL particle size and number: Small, dense LDL particles are more harmful than large, fluffy ones
  • Lipoprotein(a): A genetic risk factor for cardiovascular disease
  • High-sensitivity C-reactive protein (hs-CRP): Indicates inflammation that may contribute to heart disease

These additional markers can provide a more complete picture of your cardiovascular risk, especially if your TC:HDL-C ratio falls in a borderline range.

Taking Action on Your TC:HDL-C Ratio

Understanding your TC:HDL-C ratio is just the first step. The real power comes from using this knowledge to make informed decisions about your health. Whether your ratio is optimal or needs improvement, regular monitoring combined with targeted lifestyle changes can help you maintain or achieve better cardiovascular health.

Remember that improving your ratio is a gradual process. It typically takes 6-8 weeks of consistent lifestyle changes to see significant improvements in your cholesterol profile. Be patient with yourself and celebrate small victories along the way.

By focusing on this important biomarker and taking proactive steps to optimize it, you're investing in your long-term cardiovascular health and reducing your risk of heart disease and stroke. Your future self will thank you for the efforts you make today.

References

  1. Prospective Studies Collaboration. (2007). Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. The Lancet, 370(9602), 1829-1839.[Link][DOI]
  2. Millán, J., et al. (2009). Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention. Vascular Health and Risk Management, 5, 757-765.[PubMed][DOI]
  3. Lemieux, I., et al. (2001). Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men. Archives of Internal Medicine, 161(22), 2685-2692.[PubMed][DOI]
  4. Arsenault, B. J., et al. (2009). Lipid parameters for measuring risk of cardiovascular disease. Nature Reviews Cardiology, 8(4), 197-206.[PubMed][DOI]
  5. Calling, S., et al. (2019). Total cholesterol/HDL-C ratio versus non-HDL-C as predictors for ischemic heart disease: a 17-year follow-up study of women in southern Sweden. BMC Cardiovascular Disorders, 21, 163.[PubMed][DOI]
  6. American Heart Association. (2020). Understanding Cholesterol Levels and Numbers. Circulation, 142(20), e432-e447.[Link][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my TC:HDL-C ratio at home?

You can test your TC:HDL-C ratio at home with SiPhox Health's Heart & Metabolic Program, which includes total cholesterol and HDL cholesterol testing. The program provides CLIA-certified lab results and calculates your ratio automatically, along with personalized insights to help you improve your cardiovascular health.

What is the ideal TC:HDL-C ratio?

The ideal TC:HDL-C ratio is below 3.5, which indicates optimal cardiovascular health. Ratios between 3.5-5.0 are considered borderline, while ratios above 5.0 suggest increased risk for heart disease. Women typically have better ratios than men due to naturally higher HDL levels.

How quickly can I improve my TC:HDL-C ratio?

With consistent lifestyle changes like regular exercise, dietary improvements, and weight loss, you can see meaningful improvements in your TC:HDL-C ratio within 6-8 weeks. Some people may notice changes sooner, while others might need 3-6 months to see significant improvements.

Is the TC:HDL-C ratio more important than LDL cholesterol?

Both metrics are important, but research suggests the TC:HDL-C ratio may be a better predictor of cardiovascular risk than LDL alone. The ratio provides a more complete picture by accounting for protective HDL cholesterol, while LDL only shows one aspect of your cholesterol profile.

Can medications improve my TC:HDL-C ratio?

Yes, certain medications can improve your ratio. Statins primarily lower total cholesterol and LDL, which can improve the ratio. Niacin and fibrates can specifically raise HDL levels. However, lifestyle changes should be the first approach, with medications considered when lifestyle modifications aren't sufficient.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details